Economy
FDA Approves Pfizer Booster Shot for 16, 17-Year-Olds
The FDA cleared the Pfizer COVID-19 booster for 16- and 17-year-olds, expanding eligibility as the Omicron variant spreads. The decision permits teenagers to receive a third dose of the shot at least six months after their initial series, the Wall Street Journal reports. “The best way to minimize the spread of Covid-19 and any future […]
The FDA cleared the Pfizer COVID-19 booster for 16- and 17-year-olds, expanding eligibility as the Omicron variant spreads.
The decision permits teenagers to receive a third dose of the shot at least six months after their initial series, the Wall Street Journal reports.
“The best way to minimize the spread of Covid-19 and any future variants is getting all eligible people fully vaccinated with the first two-dose series and a booster dose as recommended,” Pfizer Chief Executive Albert Bourla said.
Pfizer has reported that volunteers in its 10,000-subject study testing boosters in people 16 years and older generated strong immune responses and experienced fewer side effects than after the second dose.
Human Events
Reporting credited to the Human Events newsroom rather than an individual byline.
Related
More Economy
